News & Updates

Intranasal oxytocin does not enhance social behaviour in children, adolescents with ASD
Intranasal oxytocin does not enhance social behaviour in children, adolescents with ASD
02 Dec 2021 byAudrey Abella

In children and adolescents with autism spectrum disorder (ASD), intranasal oxytocin did not improve social interaction or other measures of social function related to ASD, the phase II SOARS-B* trial suggests.

Intranasal oxytocin does not enhance social behaviour in children, adolescents with ASD
02 Dec 2021
Focused ultrasound shows promise in drug-resistant epilepsy
Focused ultrasound shows promise in drug-resistant epilepsy
24 Nov 2021

Low-intensity focused ultrasound can be delivered to the target zone in patients with drug-resistant epilepsy without significant adverse events, as shown in a phase I study. Moreover, the treatment produces meaningful changes in stereo-electroencephalography activity.

Focused ultrasound shows promise in drug-resistant epilepsy
24 Nov 2021